BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28049400)

  • 1. Elucidating Treatment of Alzheimer's Disease via Different Receptors.
    Ul Islam B; Khan MS; Jabir NR; Kamal MA; Tabrez S
    Curr Top Med Chem; 2017; 17(12):1400-1407. PubMed ID: 28049400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Various Proteins for the Treatment of Alzheimer's Disease.
    Islam BU; Zaidi SK; Kamal MA; Tabrez S
    Curr Drug Metab; 2017; 18(9):808-813. PubMed ID: 28164752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
    Tayeb HO; Yang HD; Price BH; Tarazi FI
    Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets.
    Islam BU; Tabrez S
    Int J Biol Macromol; 2017 Apr; 97():700-709. PubMed ID: 28111296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.
    Muñoz-Torrero D
    Curr Med Chem; 2008; 15(24):2433-55. PubMed ID: 18855672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS; Borroni MV; Barrantes FJ
    CNS Drugs; 2014 Nov; 28(11):975-87. PubMed ID: 25248971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H; Grossberg GT
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship.
    Halder D; Das S; R S J; Joseph A
    J Biomol Struct Dyn; 2023 Dec; 41(20):11286-11323. PubMed ID: 36579430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease.
    Orhan G; Orhan I; Subutay-Oztekin N; Ak F; Sener B
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):43-51. PubMed ID: 19149713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches.
    Galimberti D; Scarpini E
    Curr Aging Sci; 2010 Feb; 3(1):46-56. PubMed ID: 20298170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy.
    Zheng H; Fridkin M; Youdim MB
    Curr Drug Targets; 2012 Jul; 13(8):1089-106. PubMed ID: 22676912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview.
    Kumar A; Singh A; Aggarwal A
    Indian J Exp Biol; 2017 Feb; 55(2):63-73. PubMed ID: 30183230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
    Shinagawa S; Shigeta M
    Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy against amyloid pathology in Alzheimer's disease.
    Galimberti D; Ghezzi L; Scarpini E
    J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.